September 29, 2016
How Safe Is Propranolol for Treatment of Infant Hemangiomas? A Systematic Review Does
More Than Just Skin the Surface
Dr Lewis First, MD,MA, Editor-in-Chief, Pediatrics
The use of propranolol and timolol for treatment of infantile hemangiomas is not new news to most of us, based on the many case reports and subsequent clinical trials that herald its success as a treatment agent for this problem. What we also see on occasion are case reports and study results that suggest there can be some serious and not so serious adverse effects of using propranolol in these patients. So just what are these side effects and how common are they? Leaute-Labreze et al ( 10.1542/peds.2016-0353) decided to address these questions by performing a systematic review to better determine the safety profile of propranolol when used for this purpose in a review article being released this week.
Copyright © 2016 American Academy of Pediatrics